Scisparc presents new leadership lineup

Tel aviv, israel, jan. 27, 2022 /prnewswire/ -- scisparc ltd. (nasdaq: sprc) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the "company"), announced that its board of directors (the "board") resolved to appoint mr.

SPRC Ratings Summary

SPRC Quant Ranking